Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

2024 Annual Meeting | C46 - Child Neurology: Neuro-oncology

Sunday 04/14/24
01:00 PM - 03:00 PM MDT Add To Calendar
Colorado Convention Center | 601
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Seminar
Sonia Partap, MD
Child Neurology and Developmental Neurology, Neuro-oncology
Participants should be able to understand the current treatment strategies of pediatric CNS tumors, become familiar with the neurologic sequelae related to tumor and or cancer therapies, and anticipate late neurologic effects in survivors of these cancers.
2.00 CME credits
Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement, Quality Improvement
Intermediate
Fellow, Resident, General Neurologist, Specialist Neurologist, Advanced Practice Provider, Medical Student
Case-based, Didactic, Audience Participation

Program Materials Program Evaluations

Event Timeline
01:00 PM - 01:40 PM MDT Speaker Pediatric CNS Tumor Review and Updates
Sonia Partap, MD, Nicole Ullrich, MD, PhD, MMSci, FAAN
01:40 PM - 02:20 PM MDT Speaker Molecular Therapies in Neurocutaneous Syndromes and Low-grade Glioma
Yasmin Khakoo, MD, FAAN, FAAP
02:20 PM - 03:00 PM MDT Speaker Neurologic Toxicity in Survivors of Childhood Brain Tumors
Nicole Ullrich, MD, PhD, MMSci, FAAN
Faculty Disclosures
Sonia Partap, MD The institution of Dr. Partap has received research support from NIH.
Nicole Ullrich, MD, PhD, MMSci, FAAN Dr. Ullrich has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Astra Zeneca. Dr. Ullrich has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Wolf, Horowitz & Etlinger, LLC. The institution of Dr. Ullrich has received research support from Children's Tumor Foundation. Dr. Ullrich has received intellectual property interests from a discovery or technology relating to health care. Dr. Ullrich has received intellectual property interests from a discovery or technology relating to health care.
Yasmin Khakoo, MD, FAAN, FAAP Dr. Khakoo has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier.